October 19, 2022
Therapixel announces launch of prospective study on the utility of Artificial Intelligence (AI) as part of second reading breast cancer screening mammograms
The first French prospective clinical study to evaluate the…
May 14, 2022
Therapixel releases a new version of MammoScreen® that leverages prior exams for better accuracy
For the first time, an AI-based decision support software…
May 12, 2022
Therapixel announces close of 15 M€ series B financing to deploy MammoScreen® 2D/3D
The Company will accelerate the commercial deployment of…
November 28, 2021
Therapixel receives FDA clearance for use of its AI-based breast cancer screening software MammoScreen® on Digital Breast Tomosynthesis
AI-powered reading aid for screening 2D & 3D mammography…
February 25, 2021
Therapixel will be showcasing MammoScreen™ at the virtual ECR 2021
Stop by our booth to learn more about our FDA-cleared and…
January 12, 2021
Therapixel receives the CE mark for its Artificial Intelligence-based software (AI) MammoScreen™
This cutting-edge technology assists radiologists in the…
October 16, 2020
Therapixel and RAD-AID International Announce Breast Imaging AI Collaboration for Global Health
The collaboration donates and supports AI for making breast…
September 22, 2020
Therapixel participates in the Journées Francophones de Radiologie 2020
Experience the Award-winning MammoScreen™ at our virtual…
September 16, 2020
Therapixel is now ISO/IEC 27001 certified
Our information security management system is compliant…
July 9, 2020
Therapixel receives FDA 510(k) clearance for MammoScreen™
AI-powered reading aid for screening mammography improves…